What is the management for Acute Deterioration of Insulin Protocol (ADIP) symptoms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Acute Deterioration of Insulin Protocol (ADIP) Symptoms

For ADIP symptoms, immediate management includes temporarily stopping insulin, providing supportive care with hydration, monitoring glucose levels frequently, and treating pain with FDA-approved medications like pregabalin or duloxetine.

Understanding ADIP

ADIP, also known as Treatment-Induced Neuropathy of Diabetes (TIND), is a condition characterized by acute neurological symptoms that develop following rapid improvement in glycemic control. This typically occurs after sudden insulin protocol adjustments or intensive glycemic management.

Clinical Presentation

  • Severe neuropathic pain (burning, shooting, electric-like sensations)
  • Autonomic dysfunction (postural hypotension, gastroparesis, genitourinary issues)
  • Temporal relationship between rapid glycemic improvement and symptom onset 1

Management Protocol

Immediate Interventions

  1. Stabilize glycemic control

    • Consider slowing the rate of glycemic improvement 1
    • Avoid extreme glucose fluctuations
    • Monitor glucose levels every 4-6 hours while awake 2
  2. Pain management

    • First-line: FDA-approved medications
      • Pregabalin (300-600mg/day in divided doses)
      • Duloxetine (60-120mg/day)
      • Tricyclic antidepressants (amitriptyline 10-75mg at bedtime) 1
    • Second-line:
      • Gabapentin 300-1200mg three times daily
      • Topical capsaicin cream 0.025-0.075% applied 3-4 times daily 1
  3. Autonomic dysfunction management

    • For postural hypotension: Consider fludrocortisone if severe 1
    • For gastroparesis: Prokinetic agents 1
    • For genitourinary dysfunction: Assess bladder and residual urine volume 1

Laboratory Evaluation

  • Basic metabolic panel (Na, K, CO2, glucose)
  • Morning cortisol and ACTH levels (to rule out adrenal insufficiency)
  • Thyroid function tests
  • Check for ketones if on SGLT2 inhibitors or insulin 2

Graded Management Based on Severity

Mild Symptoms (Grade 1)

  • Continue insulin with close monitoring
  • Initiate pain management
  • Monitor glucose every 4-6 hours 2

Moderate Symptoms (Grade 2)

  • Consider temporarily holding insulin until stabilized
  • Assess need for hydration and supportive care
  • Urgent endocrine consultation
  • Initiate pain management 2

Severe Symptoms (Grade 3-4)

  • Hold insulin until patient is stabilized
  • Inpatient management with IV hydration (at least 2L normal saline)
  • Endocrine consultation
  • Aggressive pain management
  • Monitor for complications 2

Special Considerations

Sick Day Management

For patients experiencing ADIP symptoms during illness:

  • Increase fluid intake with limited caffeine
  • Consider electrolyte replacement solutions
  • Monitor blood glucose more frequently
  • Check for ketones if on SGLT2 inhibitors or insulin 2

Medications to Temporarily Hold

If ADIP is accompanied by dehydration or acute illness:

  • SGLT2 inhibitors
  • NSAIDs
  • Potassium-sparing diuretics
  • Loop diuretics
  • ACEIs/ARBs
  • Thiazide diuretics 2

Prevention and Long-term Management

  • Maintain stable glycemic control without extreme fluctuations
  • Aim for gradual improvement in HbA1c rather than rapid correction
  • Continue optimal long-term glycemic control to prevent progression
  • Regular assessment of pain reduction using standardized scales
  • Evaluation of autonomic function 1

Common Pitfalls to Avoid

  1. Failing to recognize the temporal relationship between rapid glycemic improvement and symptom onset
  2. Continuing aggressive insulin therapy despite symptoms
  3. Inadequate pain management
  4. Not monitoring for autonomic dysfunction
  5. Overlooking the need for hydration and electrolyte management

Remember that ADIP is self-limiting in many cases, but appropriate management can significantly reduce patient suffering and prevent complications.

References

Guideline

Treatment-Induced Neuropathy of Diabetes (TIND) Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.